Page last updated: 2024-09-03

ramatroban and Myocardial Ischemia

ramatroban has been researched along with Myocardial Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altavilla, D; Campo, GM; Canale, P; Caputi, AP; Faggiotto, A; Ioculano, M; Oriti, S; Saitta, A; Squadrito, F; Zingarelli, B	1

Other Studies

1 other study(ies) available for ramatroban and Myocardial Ischemia

Article	Year
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury. Agents and actions, 1993, Volume: 39, Issue:3-4 Topics: Animals; Carbazoles; Creatine Kinase; Hemodynamics; Leukocytes; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Sulfonamides; Thromboxane A2	1993

Article

Year

Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury.

Agents and actions, 1993, Volume: 39, Issue:3-4

Topics: Animals; Carbazoles; Creatine Kinase; Hemodynamics; Leukocytes; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Sulfonamides; Thromboxane A2

1993